What Factors Are Escalating the Demand Across the US Intravenous Solution Market?
The increasing prevalence of chronic diseases and the rising geriatric population have propelled substantial expansion in the US intravenous solution domain. According to detailed industry evaluation of the US Intravenous Solution Market, the market was valued at USD 3,150 million in 2024 and is projected to reach USD 8,000 million by 2035, exhibiting a CAGR of 8.84% during the forecast...
0 Σχόλια 0 Μοιράστηκε 7 Views 0 Προεπισκόπηση